Testing effectiveness (Phase 2)Ended earlyNCT03913559
What this trial is testing
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
Who this might be right for
Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital 5